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Abstract: Replication studies are increasingly conducted to confirm
original findings. However, there is no established standard how to
assess replication success and in practice many different approaches
are used. The purpose of this paper is to refine and extend a recently
proposed reverse-Bayes approach for the analysis of replication stud-
ies. We show how this method is directly related to the relative effect
size, the ratio of the replication to the original effect estimate. This
perspective leads to two important contributions: (1) the golden level
to recalibrate the assessment of replication success, and (2) a novel
approach to calculate the replication sample size based on the spe-
cification of the minimum relative effect size. Compared to the stand-
ard approach to require statistical significance of both the original and
replication study, replication success at the golden level offers uniform
gains in project power and controls the Type-I error rate even if the rep-
lication sample size is slightly smaller than the original one. Sample
size calculation based on replication success at the golden level tends
to require smaller samples than the standard approach, if the original
study is reasonably powered. An application to data from four large
replication projects shows that the replication success approach leads
to more appropriate inferences, as it penalizes shrinkage of the replic-
ation estimate compared to the original one, while ensuring that both
effect estimates are sufficiently convincing on their own.
Key Words: Power; Relative Effect Size; Replication Studies; Sample
Size; Sceptical p-value; Two-Trials Rule; Type-I error rate
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1 Introduction
Replication studies are conducted in order to investigate whether an original finding
can be confirmed in an independent study. Although replication has long been a cent-
ral part of the scientific method in many fields, the so-called replication crisis (Ioan-
nidis, 2005; Begley and Ioannidis, 2015) has led to increased interest in replication over
the last decade. These developments eventually culminated in large-scale replication
projects that were conducted in various fields (Errington et al., 2014; Open Science Col-
laboration, 2015; Camerer et al., 2016, 2018; Cova et al., 2018).
Declaring a replication as successful is, however, not a straightforward task, and
currently used approaches include significance of both the original and replication
studies, compatibility of their effect estimates, and meta-analysis of the effect estim-
ates. In order to address this lack of an accepted definition of replicability, a new
method has recently been proposed in Held (2020a). The approach combines the
analysis of credibility (Matthews, 2001a,b) with a prior-data conflict assessment (Box,
1980) to define replication success. Conceptually, replication success is declared if the
replication study is in conflict with a sceptical prior that would make the original
study non-significant.
To introduce some notation, let zo = θˆo/σo and zr = θˆr/σr denote the z-statistic of
the original and replication study, respectively. Here θˆo and θˆr are the corresponding
effect estimates (assumed to be normally distributed) of the unknown effect θ with
standard errors σo and σr, respectively. The corresponding one-sided p-values are
denoted by po = 1−Φ(zo) and pr = 1−Φ(zr), respectively, where Φ(·) denotes the
standard normal cumulative distribution function. Let c = σ2o /σ2r denote the variance
ratio of the squared standard errors of the original and replication effect estimates.
Usually, the squared standard errors are inversely proportional to the sample size of
each study, i. e. σ2o = κ2/no and σ2r = κ2/nr for some unit variance κ2. The variance
ratio c can then be identified as the relative sample size c = nr/no. The relative effect
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size
d =
θˆr
θˆo
=
1√
c
zr
zo
quantifies the size of the replication effect estimate θˆr relative to the original effect
estimate θˆo. The corresponding shrinkage of the replication effect estimate will be
denoted as s = 1− d.
Suppose the original study achieved statistical significance at one-sided level α, so
po ≤ α. The standard approach to assess replication success is based on significance
of the replication effect estimate at the same level α, i. e. the replication is considered
successful if also pr ≤ α. This approach is known in drug development as the two-
trials rule (Senn, 2007). Let zα = Φ−1(1− α) > 0 denote the z-value corresponding
to the level α, then significance of the replication effect estimate is equivalent to the
criterion
d ≥ zα
zo
√
c
. (1)
The right-hand side goes to zero for increasing c, so if the relative sample size c is large
enough, significance of the replication study can be achieved with any arbitrarily small
(but positive) relative effect size d. The approach discussed in this paper addresses
this problem as it penalizes shrinkage of the replication estimate and requires a more
appropriate criterion on the relative effect size to achieve replication success.
The paper is structured as follows. Section 2 reviews the Held (2020a) approach to
assess replication success and relates it to the relative effect size in Section 2.1. This
leads to a novel recalibration of the procedure based on the golden level (Section 2.2).
A comparison with the two-trials rule is made in Section 2.3. Section 3 introduces dif-
ferent approaches to design the replication study based on the result from the original
study. Specifically, a new approach based on the relative effect size (Section 3.1) is
compared to more traditional approaches based on the power to achieve significance
of the replication effect estimate respectively replication success (Section 3.2). Type-I
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error rates and project power of the proposed procedure are compared with the two-
trials rule in Section 4. Section 5 describes an application to data from four different
replication projects and Section 6 closes with some discussion.
2 Replication success
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Figure 1: Example of the assessment of replication success. The original study from
Pyc and Rawson (2010) has effect estimate θˆo = 0.4 on Fisher’s z scale (95%
CI from 0.05 to 0.74) and one-sided p-value po = 0.011. The left part of
the figure illustrates the reverse-Bayes derivation of the sufficiently sceptical
prior based on the original study result and the posterior with lower credible
limit fixed at zero. The comparison of the sufficiently sceptical prior with the
replication study result (θˆr = 0.15, 95% CI from 0.04 to 0.26, pr = 0.004) in
the right part of the figure is used to assess potential prior-data conflict.
Hereinafter we focus on the one-sided assessment of replication success to ensure
that replication success can only occur if the original and replication effect estimates
go in the same direction. Figure 1 illustrates the Held (2020a) approach based on a
replication study from the Social Sciences Replication Project (Camerer et al., 2018): the
significant original finding by Pyc and Rawson (2010) at one-sided level α = 0.025 is
challenged with a sceptical prior, sufficiently concentrated around zero to make the
original study result no longer convincing (Matthews, 2001a,b). Replication success is
then defined as conflict between the sceptical prior and the result from the replication
study in order to persuade the sceptic. Conflict is quantified by a prior-predictive
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tail probability pBox (Box, 1980) where a small value pBox ≤ α defines replication suc-
cess. In Figure 1 the original finding is only borderline significant, so the sufficiently
sceptical prior is fairly wide. Furthermore, there is substantial shrinkage (62%) of the
replication effect estimate and therefore hardly any conflict with the sufficiently scep-
tical prior (one-sided pBox = 0.31). We are thus not able to declare replication success
at level 2.5%.
Held (2020a) showed that if both sign(zo) = sign(zr) and
(
z2o/z
2
αS
− 1) (z2r /z2αS − 1) ≥ c (2)
hold, replication success at the one-sided level αS is achieved, where zαS = Φ
−1(1−
αS). The requirement (2) can be assessed for different values of the level αS and of
particular interest is the smallest possible value of αS where (2) holds, the so-called
sceptical p-value pS. We are thus interested in the value z2S that fulfills
(
z2o/z
2
S − 1
) (
z2r /z
2
S − 1
)
= c. (3)
There is a unique solution of (3) which defines the one-sided sceptical p-value pS = 1−
Φ (zS) where zS := +
√
z2S, provided sign(zo) = sign(zr) holds. Replication success at
level αS is then achieved if pS ≤ αS. In the introductory example based on the original
study by Pyc and Rawson (2010), the sceptical p-value turns out to be pS = 0.11.
The sceptical p-value has a number of interesting properties, see Held (2020a, Sec-
tion 3.1) for details. In particular,
pS > max{po, pr} (4)
always holds with pS ↓ max{po, pr} for c ↓ 0. Furthermore, if the p-values po and
pr are fixed, the sceptical p-value pS increases with decreasing relative effect size d.
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The first property ensures that both the original and the replication study have to be
sufficiently convincing on their own to ensure replication success. The second property
guarantees that shrinkage of the replication effect estimate is penalized.
The level for replication success αS has to be distinguished from the significance
level α associated with the ordinary p-value. Held (2020a) has used the nominal level
for replication success (αS = α) for convenience, but in the following we will propose
a recalibration of the procedure along with a new value for αS, the golden level. The
derivation is based on a natural requirement on the relative effect size (Section 2.2). In
a nutshell, the golden level ensures that for original studies which were only borderline
significant, replication success is only possible if the replication effect estimate is larger
than the original one.
2.1 Relative effect size
Without loss of generality we assume that θˆo > 0 and that po < αS has been observed
in the original study, otherwise it would be impossible to achieve replication success at
level αS because pS is always larger than po due to (4). The condition (2) for replication
success can then be re-written as
zr ≥ zαS
√
1 + c/(K− 1) =: zminr , (5)
where K = z2o/z2αS > 1. The right hand-side of (5) is the minimum replication z-
value zminr required to achieve replication success. Note that the minimum replication
z-value increases with increasing c, so increasing the sample size leads to a more
stringent success requirement for the replication p-value. Equation (5) can be further
transformed to a condition on the relative effect size
d ≥
√
1 + c/(K− 1)√
K
√
c
=: dmin. (6)
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To achieve replication success, the relative effect size d must be at least as large as
the right-hand side of (6), the minimum relative effect size dmin, a function of K and
the relative sample size c. Note that the minimum relative effect size simplifies to
dmin = 1/
√
K− 1 for c = 1. If the relative sample size becomes very large, i. e. c → ∞,
we have dmin ↓ d∞ where
d∞ = 1/
√
K(K− 1). (7)
This shows that the minimum relative effect size in (6) does not go to zero for increas-
ing c, so replication success cannot be achieved if the relative effect size d is smaller
or equal to d∞, no matter how large the replication study is. This has to be contrasted
with the standard assessment of significance of the replication study, where the cor-
responding criterion (1) can be achieved for any positive relative effect size, regardless
of how small, provided the replication sample size is sufficiently large.
2.2 The golden level
Significance of both the original and the replication study at level α is a necessary but
not sufficient requirement for replication success at the nominal level (αS = α). The
nominal level may therefore be too stringent. It is more reasonable to calibrate the
procedure in such a way that to establish replication success, original and replication
study do not both necessarily need to be significant at level α, provided that the rep-
lication effect estimate does not shrink compared to the original one. We therefore
choose a level αS such that a borderline significant original study (po = α) cannot
lead to replication success if there is shrinkage s > 0 of the replication effect estimate.
Mathematically, this translates to setting d∞ = 1 and K = z2α/z2αS in (7) and leads to the
quadratic equation K(K − 1) = 1 with solution K = ϕ where ϕ = (√5 + 1)/2 ≈ 1.62
is known as the golden ratio. Solving for zαS gives
zαS = zα/
√
ϕ (8)
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and the corresponding golden level αS = 1−Φ(zαS = zα/
√
ϕ) for replication success.
This is our recommended default choice to assess replication success and we will study
its properties in the following in more detail. For zα = 1.96 (one-sided α = 0.025), the
golden level is αS = 0.062. In the introductory example based on the replication of
the Pyc and Rawson (2010) study, the sceptical p-value is pS = 0.11 > 0.062, so the
replication study was not successful at the golden level.
The condition pS ≤ αS for replication success at the golden level is equivalent to
zS ≤ zα/√ϕ, i. e. zS√ϕ ≤ zα. In practice it may be preferable to recalibrate the sceptical
p-value pS = 1−Φ(zS) to p˜S = 1−Φ(zS√ϕ), which then needs to be compared to α
(rather than αS) to assess replication success and can thus be interpreted on the same
scale as an ordinary p-value. For example, the recalibrated sceptical p-value for the
replication of Pyc and Rawson (2010) turns out to be p˜S = 0.061.
2.3 Comparison with the two-trials rule
A useful benchmark for comparison is the two-trials rule in drug development (Kay,
2015, Section 9.4), which requires “at least two adequate and well-controlled studies,
each convincing on its own, to establish effectiveness” (FDA, 1998, p. 3). This is usually
achieved by independently replicating the result of a first study in a second study, both
significant at one-sided level α = 0.025. It is worth noting that in practice the two trials
are often run in parallel (Senn, 2007), so do not exactly resemble the replication setting.
The main difference between the replication success and the two-trials rule approach
concerns how shrinkage of the replication effect estimate is handled. Figure 2 illus-
trates that shrinkage is penalized in the assessment of replication success, i. e. the
original p-value needs to be quite small to achieve replication success for a relative
effect size d < 1. In contrast, significance of the replication study can be achieved even
if there is substantial shrinkage, provided the replication sample size is large enough.
It is interesting to directly compare the two-trials rule and replication success at the
9
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Figure 2: Comparison of replication success at the golden level (pS ≤ αS = 0.062) and
the two-trials rule (po ≤ 0.025 and pr ≤ 0.025). Red hatched areas indicate
that success is impossible for original p-value po and relative effect size d. In
the white areas success is possible and depends on the relative sample size c
as indicated by the grey lines.
golden level in terms of their stringency, i. e. the required relative effect size d to fulfill
the criteria (1) and (6), respectively. If the original p-value is not significant at level α,
only replication success can be achieved, but will require a replication effect estimate
larger than the original one. If the original p-value is smaller than α, then the situation
depends on the relative sample size c. For example, when the replication sample size
is chosen to be the same as in the original study (c = 1) and α = 0.025, original studies
with a p-value larger than 0.006 will require a smaller relative effect size d with the
two-trials rule, while p-values smaller than 0.006 will require a smaller relative effect
size d with the replication success method. This illustrates that the latter method is less
stringent than the two-trials rule if the original study is already sufficiently convincing.
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3 Design of the replication study
The methodology developed in the previous section is tailored for the analysis of
replication studies, but can be adapted for the purpose of their design. In the following
sample size calculation based on the minimum relative effect size is introduced and
compared with the standard approach based on power.
3.1 Design based on relative effect size
Equation (6) can be inverted such that the replication sample size can be computed
based on the specification of the minimum relative effect size. Specifically, the required
relative sample size c to achieve replication success at level αS with minimum relative
effect size dmin is
cRS =

K−1
d2minK(K−1)−1
if dmin > d∞
NA else,
(9)
where d∞ is the bound (7) on the relative effect size. This novel way of calculating the
sample size requires the specification of the minimum relative effect size dmin which
can still be considered as acceptable. In practice, this will strongly depend on the field
and the phenomenon studied by the researcher. We therefore do not recommend a
default value, but rather that its specification should be based on domain knowledge.
The relative sample size (9) is available if dmin > d∞, for dmin ↓ d∞ we have cRS → ∞.
For an original study with po = 0.025 and the golden level αS = 0.062, the bound is
d∞ = 1. This ensures that for original studies that were only borderline significant,
a necessary requirement for replication success is a replication effect estimate larger
than the original one (dmin > 1).
The two-trials rule can also be formulated in terms of the relative effect size. Re-
arranging (1) gives the required relative sample size to fulfill the two-trials rule at level
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α with minimum relative effect size dmin:
c2TR =

z2α
d2min z
2
o
if zo ≥ zα
NA else.
(10)
If both (9) and (10) are available we have K = z2o/z2αS = ϕ z
2
o/z2α at the golden level,
so c2TR = ϕ/(d2minK) and hence the sample size ratio is
cRS/c2TR =
ϕ− 1
1− (d∞/dmin)2 . (11)
Now ϕ− 1 ≈ 0.62, so the relative sample size cRS can be up to 38% smaller than c2TR if
d∞/dmin is small. If d∞/dmin > ϕ− 1, then the replication success method at the golden
level requires a larger sample size than the two-trials rule. This can be re-written with
(7) to K < 1/2 +
√
ϕ2/d2min + 1/4. For α = 0.025, this translates to po > 0.011 for
dmin = 1 and po > 0.007 for dmin = 0.8, showing that the replication success approach
requires a larger sample size than the two-trials rule only if the p-value of the original
study is relatively large.
It is interesting to compute the distribution of the sample size ratio (11) under the
null respectively alternative hypothesis. The bound d∞ in (11) depends on K which in
turn depends on zo whose distribution is either N(0, 1) (under the null hypothesis) or
N(µ, 1) (under the alternative hypothesis), here
µ = Φ−1(1− α) +Φ−1(1− β), (12)
where α is the assumed significance level and 1− β the power to detect the assumed ef-
fect in the original study (Matthews, 2006, Section 3.3). The distribution of the sample
size ratio (11) can then be computed based on the implied truncated normal distribu-
tion of zo. Table 1 gives the median, 10% and 90% quantile under the null and under
the alternative hypothesis (with power of 80% and 90%, respectively) for minimum
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relative effect size dmin = 0.8, 0.9 and 1. Under the null hypothesis, the median sample
size ratio is between 1.07 and 1.22, so slightly larger with (9) compared to (10). Under
the alternative, however, the median sample size ratio is between 0.65 and 0.71. This
illustrates that the replication success approach tends to require a smaller sample size
than the two-trials rule, if the alternative hypothesis is true and the original study is
reasonably powered.
Minimum relative effect size dmin
Hypothesis 0.8 0.9 1
Null 1.22 [0.75, 5.22] 1.14 [0.73, 4.66] 1.07 [0.71, 4.20]
Alternative (80% power) 0.71 [0.64, 1.35] 0.69 [0.63, 1.22] 0.68 [0.63, 1.12]
Alternative (90% power) 0.67 [0.63, 1.04] 0.66 [0.63, 0.96] 0.65 [0.63, 0.90]
Table 1: Quantiles of the distribution of the sample size ratio cRS/c2TR (median with 10
and 90% quantile in brackets)
Minimum relative effect size dmin
Hypothesis 0.8 0.9 1
Null 0.018 0.021 0.025
Alternative (80% power) 0.76 0.78 0.80
Alternative (90% power) 0.87 0.89 0.90
Table 2: Probability that the condition (13) is fulfilled
However, we need to assume that both cRS and c2TR exist, which is the case if both
dmin > d∞ and zo ≥ zα holds. For dmin ≤ 1 this reduces to the condition
zo >
zα√
ϕ
√
0.5 +
√
1/4 + 1/d2min. (13)
Table 2 gives the probability that condition (13) holds. This has been calculated with
Monte Carlo simulation. For dmin = 1, the right-hand side of (13) reduces to zα, so
this probability is equal to the significance level respectively the assumed power. For
dmin < 1 the probability slightly decreases, for example under the null hypothesis and
13
for dmin = 0.8 the probability is 0.018 rather than 0.025.
3.2 Design based on power
The sample size of the replication study is usually calculated based on the estimate
from the original study and a certain level of predictive or conditional power, depend-
ing on whether or not the uncertainty of the estimate is taken into account. Given
that there is an effect, the power for replication success is the probability of replication
success (pS ≤ αS) (Held, 2020a, Section 4) while the power for significance is the prob-
ability of a significant replication study (pr ≤ α). The latter equals the power of the
two-trials rule (2TR) provided the original study was significant (po ≤ α), otherwise
the power is zero.
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Figure 3: Power calculations for a replication study with sample size equal to the ori-
ginal study (c = 1, left) and increased by a factor of c = 5 (right). Shown
is conditional (solid) and predictive (dashed) power for the two-trials rule
(2TR) at level α = 0.025 and for replication success (RS) at the correspond-
ing nominal and golden level as a function of the one-sided p-value of the
original study. Power values of exactly zero are omitted.
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Figure 3 compares the power for replication success at the golden and at the nominal
level with the power of the two-trials rule for relative sample size c = 1 (left) and c = 5
(right) as a function of the one-sided p-value from the original study po. Note that the
predictive power is always closer to 50% due to incorporation of additional uncertainty
(Held, 2020a; Micheloud and Held, 2020). Furthermore, the two-trials rule requires a
significant original study and hence it is impossible to power a replication study when
po > 0.025. For a replication study of the same size as the original study (c = 1),
the probability of a significant replication result is only 50% if the original study is
borderline significant (Goodman, 1992). For c = 5 the conditional power of the two-
trials rule is 99% and the predictive power 84%. For very large c (c → ∞) conditional
power is 100%, independently of the original study result, whereas predictive power
cannot be larger than 1− po (Micheloud and Held, 2020). The power for replication
success at the golden level is larger than the power of the two-trials rule if the original
p-value is sufficiently small. Power curves for replication success at the nominal level
are always smaller than for the golden level and approach zero for po ↑ 0.025, whereas
the power at the golden level is positive for any po < 0.062.
4 Error rates
Although Bayesian methods do not rely on the frequentist paradigm of repeated test-
ing, it is still useful to investigate the frequentist operating characteristics of Bayesian
methods (Dawid, 1982; Rubin, 1984; Grieve, 2016), and this also holds for the proposed
reverse-Bayes assessment of replication success. In the following we assume that none
of the two studies have been conducted and investigate the Type-I error rate and the
project power (Maca et al., 2002).
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4.1 Type-I error rate
The Type-I error rate of the two-trials rule is simply α2 for any value of the relative
effect size c. In contrast, the Type-I error rate of the proposed replication success
assessment depends on c. For c = 1, Held (2020a, Section 3) showed that z2S in (3)
simplifies to half the harmonic mean of the squared test statistics z2o and z2r . The con-
nection z2S = z
2
H/4 to the harmonic mean χ
2 test statistic z2H (Held, 2020b), which has
a χ2(1)-distribution under the null hypothesis, makes it straightforward to compute
the Type-I error rate for c = 1 at level αS:
T1E =
{
1−Φ
[
2Φ−1 (1− αS)
]}
/2. (14)
For the golden level αS = 0.062 at α = 0.025, the Type-I error rate (14) is 0.0515%, only
slightly less than the Type-I error rate α2 = 0.0625% of the two-trials rule. For compar-
ison, the Type-I error rate at the nominal level αS = 0.025 is 0.0022%, so considerably
smaller than 0.0625%.
For c 6= 1, the Type-I error rate can be calculated through numerical integration:
T1E =
∞∫
zαS
Pr(zr ≥ zminr | zo, c, αS) φ(zo) dzo, (15)
where φ(·) denotes the standard normal density function. The first term in the integral
of (15) is the probability of replication success at level αS conditional on a fixed original
test statistic zo and a relative sample size c. This can be computed with equation (5) as
Pr(zr ≥ zminr | zo, c, αS) = 1−Φ(zminr ) because zr ∼ N(0, 1) under the null hypothesis.
The left plot in Figure 4 displays the Type-I error rate for α = 0.025 as a function of
the relative sample size c. It can be seen that the Type-I error decreases with increasing
relative sample size c. Due to (4), the Type-I error rate of the nominal level is always
below the target 0.0625%. Although the Type-I error will eventually attain α2 in the
16
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Figure 4: Type-I error rate (left) and project power (right) for fixed relative sample size
c. Results are given for replication success (RS) at the nominal and golden
level and compared with the two-trials rule (2TR) at α = 0.025. The power of
the original study is 90%
limit c ↓ 0 (Held, 2020a, Section 3.4), the nominal level seems to be too stringent for
realistic values of c. The Type-I error rate of the golden level is smaller than 0.0625%
for c > 0.85. Appropriate Type-I error control is thus ensured even for replication
studies where the sample size is slightly smaller than in the original study.
4.2 Project power
Under the alternative we have zo ∼ N(µ, 1) where µ, as given in (12), depends on
the assumed significance level α and the power 1− β to detect the assumed effect in
the original study with a standard significance test (Matthews, 2006). In the following
α = 0.025 and 1− β = 90% are used. The power of a significant replication study is
Φ(
√
cµ− zα), so depends on both µ and the relative sample size c. The project power
of the two-trials rule is therefore (1− β)Φ(√cµ− zα).
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The project power for replication success is computed as
PP =
∞∫
zαS
Pr(zr ≥ zminr | zo, c, αS) φ(zo − µ) dzo, (16)
again with µ as given in (12), and shown in the right plot of Figure 12 as a function
of c. For the golden level, the project power quickly increases to values above 90%,
whereas the nominal level only reaches around 80% project power. The project power
based on the two-trials rule is shown for comparison, which is always smaller than for
the golden rule and converges to 90% for large c.
4.3 Adaptive designs
In practice the sample size of the replication study is usually chosen based on the
result of the original study. We may distinguish four different methods. The first two
calculate the relative sample size based on the relative effect size d using formula (9)
or (10), see Section 3.1. The other two calculate the relative sample size based on the
power to achieve replication success or to fulfill the two-trials rule, see Section 3.2. As
before we distinguish whether the analysis was based on replication success or the
two-trials rule.
Calculation of Type-I error and project power can still be done with (15) respectively
(16), noting that the relative sample size c in Pr(zr ≥ zminr | zo, c, αS) now depends on zo.
The results are given in Supplementary Material and can be summarized as follows:
Replication success in the analysis provides Type-I error control at the α2 = 0.0252
level of the two-trials rule, if the replication study is powered to detect the effect from
the original study with power 60% or larger. This holds both for design based on
replication success and the two-trials rule. Likewise, an analysis based on replication
success controls the Type-I error for any minimum relative effect size dmin < 1.04
specified in the design based on replication success as described in Section 3.1. If
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design is based on the two-trials rule, then the relative effect size has to be slightly
smaller (dmin < 0.97).
Turning to project power, the uniformly better performance of replication success
over the two-trials rule for fixed design shown in Figure 4 directly transfers to the
adaptive designs with project power based on replication success in the analysis being
always larger than project power based on the two-trials rule. Not surprisingly, design
methods which require a smaller replication sample size lead to a smaller project
power. This is the case if the design was based on the relative effect size for replication
success rather than for the two-trials rule, where the median replication sample size
of the former is considerably smaller than the latter, see Table 1.
5 Application
In this section, we illustrate the proposed methodology using data from four replic-
ation projects. All four projects reported effect estimates that were transformed to
correlation coefficients (r). This scale allows for easy comparison of effect estimates
from studies that investigate different phenomena, as it is bounded to the interval
between minus one and one. Moreover, the Fisher z-transformation (θˆ = tanh−1(r))
can be applied to the correlation coefficients, resulting in the transformed estimates be-
ing asymptotically normal with variance which is only a function of the study sample
size n, i. e. Var(θˆ) = 1/(n− 3) (Fisher, 1921).
The first data set comprises the results from the Reproducibility Project: Psychology
(Open Science Collaboration, 2015), whose aim was to replicate 100 studies, all of
which were published in three major Psychology journals in 2008. For our purpose
only the 73 study pairs from the “meta-analytic” subset are considered, since only for
these studies the standard error of the Fisher z-transformed effect estimates can be
computed (Johnson et al., 2016). The second data set comes from the Experimental Eco-
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nomics Replication Project (Camerer et al., 2016) which attempted to replicate 18 exper-
imental economics studies published in two high impact economics journals between
2011 and 2015. The third data stem from the Social Sciences Replication Project (Camerer
et al., 2018) where 21 replications of studies on the social sciences were carried out,
all of which were originally published in the journals Nature and Science between 2010
and 2015. The last data set originates from the Experimental Philosophy Replicability
Project (Cova et al., 2018) which involved 40 replications of studies from the emerging
field of experimental philosophy. Since only for 31 studies effective sample size for
original and replication study were available simultaneously, only these pairs were
included. For more information on the data sets see also Pawel and Held (2020).
5.1 Analysis
Table 3 presents overall results for each of the replication projects. While the me-
dian relative effect size is below one for all of the four projects, there are still large
differences. For example, the median relative effect size is only 0.29 in the psycho-
logy project, whereas it is 0.86 in the philosophy project. The degree of shrinkage is
also reflected in the success rates (according to the two trials rule and the replication
success approach), which are around 30% for the former and more than 70% for the
latter. The percentage of successful replications is similar for the two-trials rule and
the replication success approach, but there are discrepancies in all projects expect for
Experimental Economics.
Figure 5 displays the relative effect size d versus the original p-value po for each
study pair and stratified by project. Note that one study pair from the philosophy
project is not shown due to extremely small original p-value and another study pair
from the psychology project is not shown due to a very large relative effect size. We can
see that for most of the study pairs, the replication success approach and the two-trials
rule lead to the same conclusion, only six replications show conflicting results. They
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Table 3: Results for each replication project: Relative effect size d (median with 25%
and 75% quantiles on Fisher’s z scale), percentage of successful replications
with the two-trials rule (2TR) and the replication success (RS) approach (at the
golden level), and number of studies where the methods disagree.
Project relative effect size d 2TR (%) RS (%) discrepant
Psychology 0.29 [0.03, 0.77] 28.8 30.1 3/73
Social Sciences 0.52 [0.13, 0.65] 61.9 52.4 2/21
Experimental Philosophy 0.86 [0.47, 1.12] 74.2 71.0 1/31
Experimental Economics 0.67 [0.35, 0.92] 55.6 55.6 0/18
Schmidt and Besner (2008)
Oberauer (2008)
Payne, Burkley, and Stokes (2008)
Nichols (2006)
Balafoutas and Sutter (2012)
Pyc and Rawson (2010)
Psychology Social Sciences
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Figure 5: Green indicates that replication success was achieved at the golden level
while orange indicates that it was not. The diamonds mark studies where
the replication success approach and the two-trials rule disagree. The dashed
red line indicates the bound below which replication success is impossible at
the golden level with α = 0.025.
are highlighted with diamonds in Figure 5 and their characteristics are summarised in
Table 4. Two studies from the psychology project show replication success but fail the
two-trials rule. These studies show p-values that are slightly above the significance
threshold in either original or replication study, but do not exhibit much shrinkage;
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Table 4: Characteristics of studies for which the replication success approach (at the
golden level) and the two-trials rule disagree (at one-sided α = 0.025). Shown
are relative sample size c, relative effect size d, original, replication and recal-
ibrated sceptical p-value po, pr and p˜S.
Study Project c d po pr p˜S
Schmidt and Besner (2008) Psychology 2.58 1.28 0.028 < 0.0001 0.024
Oberauer (2008) Psychology 0.60 0.67 0.0003 0.035 0.017
Payne et al. (2008) Psychology 2.65 0.41 0.001 0.023 0.031
Balafoutas and Sutter (2012) Social Sciences 3.48 0.52 0.009 0.011 0.04
Pyc and Rawson (2010) Social Sciences 9.18 0.38 0.011 0.004 0.061
Nichols (2006) Experimental Philosophy 9.40 0.49 0.015 0.0006 0.049
In the replication of Oberauer (2008), the replication p-value was pr = 0.035, a little
too large to pass the two-trials rule. However, as the replication effect estimate shrunk
only about 30% compared to the original one, replication success is still achieved.
Conversely, the original p-value po = 0.028 in Schmidt and Besner (2008) was just
above the significance level, yet the replication led to a highly significant result pr <
0.0001 with the effect estimate being even 30% larger than the original counterpart,
which therefore also resulted in replication success.
The remaining conflicting studies do not show replication success despite passing
the two-trials rule. In all cases, there is substantial shrinkage of the replication effect
estimate compared to the original one. For instance, in the replication study of Pyc
and Rawson (2010), the estimate shrunk by 62% and the replication p-value was only
significant because the sample size was increased by a factor of c = 9.2.
5.2 Design
Suppose that the four replication projects have not been conducted yet and we want to
determine the sample size of the replication studies. The left plot in Figure 6 displays
the percentage of original studies for which a finite replication sample size is available
to achieve replication success (at the golden level with α = 0.025) as a function of the
required relative effect size dmin and stratified by replication project. If we require the
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replication effect estimate to be at least as large as the original one (dmin = 1), a finite
replication sample size is available for all original studies which were significant at
α = 0.025. This is the case for all studies of the Social Science project, but not for the
other three projects, where replication attempts have been made also for some non-
significant original findings. For dmin < 1, the proportion decreases since the original
studies have to be more convincing to achieve replication success. For dmin = 0.8 a
finite replication sample size exists for around 85% of the studies. In the following, we
will fix the minimum relative effect size dmin at this value.
The right plot in Figure 6 shows a comparison of the required relative sample size
of the replication study based on the replication success approach with a minimum
relative effect size of dmin = 0.8 to the two-trials rule with 80% power to detect the
original effect estimate at the 2.5% significance level (one-sided). The violin densities
and medians are based on studies for which both methods have a finite replication
sample size. We can see that the relative sample size c is smaller for the replication
success approach in the majority of the cases. Also the median relative sample size c
is smaller for the replication success approach compared to the two-trials rule in all
replication projects, illustrating that the replication success approach can lead to more
efficient designs.
6 Discussion
In this paper, we have expanded on the replication success approach introduced in
Held (2020a) and demonstrated its advantages over alternative methods such as the
two-trials rule. In particular, the method provides an attractive compromise between
hypothesis testing and estimation, as it penalizes shrinkage of the replication effect
estimate compared to the original one, while ensuring that both are statistically sig-
nificant to some extent. For instance, the method will indicate only a low degree of
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Figure 6: Percentage of original studies for which a finite replication sample size to
achieve replication success (at the golden level with α = 0.025) is available
as a function of the relative effect size d (left). Comparison of the required
relative sample size c determined with the replication success (RS) approach
based on minimum relative effect size of dmin = 0.8 and the two trials rule
(2TR) with 80% conditional power (right). Studies where the relative sample
size c is smaller for the replication success approach are shown in blue, stud-
ies where it is larger in red. Green circles indicate original significant studies
for which it is impossible to achieve replication success.
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replication success when the replication study shows a much smaller but statistically
significant significant effect estimate, whereas it can still indicate a large degree of
success when either original or replication p-value are slightly above the significance
level, provided their effect estimates are compatible.
We further refined the method by proposing the golden level, a new threshold for
replication success. It guarantees that borderline significant original studies can only
be replicated successfully if the replication effect estimate is larger than the original
one. Compared to the two-trials rule, the golden level offers uniform gains in project
power and controls the Type-I error rate if the replication sample size is not too small
(c > 0.85). Empirical evaluation of data from four replication projects highlights that
in most cases the methods are in agreement, however, for the study pairs where the
approaches disagree, the replication success approach seems to lead to more sensible
conclusions.
With this paper we further advanced the reverse-Bayes methodology for the analysis
and design of replication studies, yet certain limitations and opportunities for future
research remain: First, assuming normality of the effect estimates may be questionable,
especially for small sample sizes, and more robust distributional assumptions could be
considered. Second, in some types of analyses (e. g. regression or ANOVA) the effect
estimate is a vector and the approach would need suitable adaptations. Finally, there is
a recent trend to not only conduct one but several replications for one original study.
Also for this situation, the method would need to be adapted, e. g. the replication
estimates could be first synthesized and an analysis of replication success could be
performed subsequently.
Despite a lack of agreement as to which statistical method should be used to eval-
uate replication studies, conclusions based on different methods usually agree. Nev-
ertheless, in some cases, classical methods such as the two-trials rule may produce
anomalies. We argue that the replication success approach improves upon existing
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methods leading to more appropriate inferences and decisions that better reflect the
available evidence.
Data and Software Availability Data analyzed in this article and software are avail-
able in the R-package ReplicationSuccess, which can be installed by running follow-
ing command in an R console: install.packages("ReplicationSuccess", repos=
"http://R-Forge.R-project.org"). Further information on data preprocessing can
be found on the corresponding help page (with the command ?RProjects).
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The assessment of replication success based on relative
effect size
Supplement: Type-I error rate and project power of adaptive
designs
Leonhard Held, Charlotte Micheloud and Samuel Pawel
17th September 2020
In practice the sample size of the replication study is usually chosen based on the
result of the original study. We distinguish four different methods. The first two
calculate the relative sample size based on the relative effect size d, either based on
replication success or on the two-trials rule. The other two calculate the relative sample
size based on power, again for replication success or the two-trials rule. We show
results for both conditional and predictive power. Calculation of the Type-I error and
the project power can be done with numerical integration in all cases.
First suppose that the sample size calculation is aiming to achieve replication success
based on the specification of the relative effect size d. This is shown in Figure 1 (top
left). It is re-assuring that any relative effect size smaller than 1.04 will maintain the
Type-I error rate α2 = 0.0625% of the two-trials rule. We could also aim to fulfill the
two-trials rule rather than replication success in the design of the replication study, see
Figure 1 (top right). Type-I errors are slightly increased now with any relative effect
size smaller than 0.97 maintaining the Type-I error rate of the two-trials rule.
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Figure 1: Type-I error rate for adaptive designs. In the top row the relative sample
size was determined after the original study has been conducted based on
specification of the relative effect size. In the bottow row the relative sample
size was determined based on specification of the power (solid lines repres-
ent conditional, dashed lines predictive power). Results in the left column are
based on design for replication success at the golden level at α = 0.025. The
right column is based on a design to achieve the two-trials-rule at α = 0.025.
The bottom left plot of Figure 1 shows the Type-I error rate if the sample size was
calculated based on a pre-specified power for replication success. The replication
success approach controls the Type-I error for any conditional power larger than 47%.
The Type-I error based on predictive power is slightly smaller for any power > 50%.
Slightly larger values of the Type-I error rate are obtained if sample size calculation
was based on the power to fulfill the two-trials rule (bottom right). The conditional
version is the current standard in many replication projects and controls the Type-I
2
error for any power larger than 53%.
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Figure 2: Project power for adaptive designs. In the top row the relative sample size
was determined after the original study has been conducted based on spe-
cification of the relative effect size. In the bottow row the relative sample
size was determined based on specification of the power (solid lines repres-
ent conditional, dashed lines predictive power). Results in the left column
are based on design for replication success, in the right column based on
design to achieve the two-trials-rule.
The four plots of Figure 2 show the project power for the different adaptive design.
We now distinguish whether the replication success approach or the two-trials rule has
been used in the design and in the analysis, respectively. The project power (top left
plot) decreases with increasing relative effect size for replication success in the design
(top left plot). Project power is 10-20% larger if the replication success approach rather
than the two-trials rule is used in the analysis. A similar pattern can be seen if the
3
design was based on specification of relative effect size for the two-trials rule, where
project power is in general increased due to the increased sample size.
The bottom left and right plots show the project power if the study was powered for
replication success (left) respectively the two-trials rule (right). Project power based on
replication success reaches values of around 70-80% if the power used in the sample
size calculation was reasonably high (>80%). Values for predictive power are some-
what lower, in particular for large values of the power for replication success, where
the probability that the replication sample size does not exist increases. A similar
pattern can be seen if the design was based on the power to fulfill the two-trials rule,
where the project power based on predictive power design is now slightly larger than
for conditional power.
4
